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Background. To evaluate the prevalence and the importance of anthropometric indexes on metabolic syndrome (MetS) among
young adolescents in Taiwan. Methods. We conducted a cross sectional survey to obtain a representative sampling among Taipei
adolescents in 2003, totally enrolled of 1,562 adolescents (764 boys and 798 girls) from age 11 to 15. We used modiﬁed NCEP-
ATP III criteria to diagnose metabolic syndrome in young adolescents including: blood pressure 90th percentile, fasting glucose
90th, TG  90th, HDL-C  10th, and BMI or WC  90th according to age and gender speciﬁc recommendations. Results.T h e
overallprevalenceofMetSwas4.8%forboysand3.9%forgirls.BMIandWCweresigniﬁcantlyassociatedwithMetSforbothboys
and girls, even after adjusting for age, cigarette smoking, alcohol drinking and pubertal status. However, after further adjusting for
B M Io rW C ,W Cf o rb o y s( O R= 1.14, 95% CI = 1.05–1.24) and BMI for girls (OR = 1.36, 95% CI = 1.13–1.64) were signiﬁcantly
associated with MetS. Conclusions. Adolescents with abnormal BMI or waist circumference had 10 to 20 times higher odds of MetS
when compared to normal subjects. Obesity, either general or central adiposity, may play an important role in the development of
MetS among adolescents.
1.Background
In the last 30 years, socioeconomic growth and changes in
life style patterns have been associated with the increasing
prevalence and the clustering of chronic diseases. The main
causes of death in Taiwan have shifted from infectious
diseases to chronic diseases such as malignancies, cardiovas-
culardisease,diabetic mellitus,andhypertension[1].Insulin
resistance, dyslipidemia, and abdominal obesity became
important independent and emergent cardiovascular risk
factors in developing and developed countries.
Metabolic syndrome (MetS) is a cluster of multiple
cardiometabolic risk factors, and its components include
abdominal obesity, dyslipidemia, high blood pressure (BP),
insulin resistance, (impaired glucose metabolism or dia-
betes), and proinﬂammatory and prothrombotic status [2].
This clustering of several cardiometabolic risk factors was
ﬁrst proposed in 1920 [3]. However, it was not until 1998
that the World Health Organization (WHO) named these
clustering characteristics as “insulin resistance syndrome”
a n dd e ﬁ n e di t sc o m p o n e n t sa n dc r i t e r i a[ 4]. After that,
diﬀerent deﬁnitions and criteria were proposed, such as
the third report from the National Cholesterol Education
Program (NCEP), the European Group for the Study of
Insulin Resistance (EGIR), American Association of Clinical
Endocrinologists (AACE), and the International Diabetes
Federation (IDF) in 2005 [2, 5–7].
The risk factors for metabolic syndrome include age,
gender, race, lifestyle, obesity, and heredity [8–15]. Many
studies have shown that metabolic syndrome is positively
associated with the morbidity and mortality from cardiovas-
cular diseases and Type 2 diabetes in adulthood [12, 16–20].
The prevalence of MetS constantly increases with increased
age [10] and is becoming one of the most important public
health issues in the world.
However, metabolic syndrome can be traced not only in
adultsbutalsoinchildhoodandadolescents[10].Inthepast,
theprevalenceofMetSinadultshasbeeninvestigatedaround2 ISRN Cardiology
the world; [11, 21–24] but recently, many studies focus on
children and adolescents and use diﬀerent criteria to discuss
the prevalence of MetS [10, 25–29]. More important, for
obesityandmetabolicsyndromeshouldbepreventedasearly
as possible.
The purpose of this study is to evaluate the prevalence of
MetS among young adolescents in Taiwan. Furthermore, this
manuscript also address the importance of anthropometric
indices, such as body mass index (BMI) and/or waist
circumference(WC)whichmayrepresentdiﬀerentadiposity,
to identify the odds of MetS among young adolescents in
Taiwan.
2.MaterialsandMethods
2.1. Study Design and Sampling. We conducted a cross-
sectionalsurveyamongjuniorhigh-school studentsinTaipei
during the year 2003 to obtain a representative distribution
of demographic, lifestyle, and biochemical characteristics
among young adolescents. The sampling method and results
havebeendescribedelsewhere[30].Brieﬂy,afteramultistage
sampling of 85 junior high-schools, we randomly selected
1,797 students for our survey. We excluded 235 subjects who
refused to participate or had missing or incomplete data, so
the ﬁnal analyses included 1,562 subjects (a response rate
around 87%) between 11–15-year-old (764 boys and 798
girls). This human subjects research was approved by the
Institutional Review Board of our institution.
2.2. Study Methods. All participants completed a structured
questionnaire that included dietary patterns, lifestyle, such
as cigarette smoking and alcohol use, and pubertal status
(by asking about the development of penis/testes and
pubic hair for boys and breast growth and pubic hair for
girls). Anthropometric measurements included body height,
body weight, BMI, waist circumference, hip circumference,
systolic blood pressure (SBP), and diastolic blood pressure
(DBP) and were assessed by trained research technicians.
Body height was recorded to the nearest 0.1cm while
subjects were barefoot and wearing light indoor clothing.
Body weight was recorded to the nearest 0.1kg using a
segmental body composition analyzer (Tanita Corp., Tokyo,
Japan) [31].Body massindex (BMI)wascalculatedasweight
in kilograms divided by the square of height in meters. Waist
circumferencewasmeasuredtothenearest0.1cmatthelevel
of the midpoint between the inferior margin of the last rib
and the iliac crest. Hip circumference was measured 4cm
below the anterior superior process of the iliac spine to the
nearest 0.1cm [32].
Blood pressure was measured on the right arm after
patients rested for ten minutes in a sitting position, using
an appropriately sized cuﬀ of a HEM-740C automatic digital
blood pressure monitor (Omron Corp., Tokyo, Japan) [33].
After 10–12 hours of fasting overnight, a 10mL venous
blood specimen was collected using venous containers.
Serum concentrations of TG and glucose were measured
withrandoxreagentonaHitachi7150autoanalyzer(Hitachi,
Tokyo, Japan) [34–36]. HDL-C was measured enzymatically
with Daiichi reagent on an Olympus AU600 autoanalyzer
(Olympus, Tokyo, Japan) [35].
2.3. Deﬁnition of Metabolic Syndrome. Since there is no clear
deﬁnition of metabolic syndrome for adolescents in Taiwan,
we modiﬁed the NCEP-ATP III criteria for our population.
The cut-oﬀ points for each variable used age- and gender-
speciﬁc 90th percentile criteria, except that HDL-C used the
10th percentile criteria among this study population. The
presence of three or more of the following components were
considered metabolic syndrome in study subjects (1) blood
pressure (SBP or DBP) 90th percentile, (2) fasting glucose
90th percentile, (3) TG 90th percentile, (4) HDL-C 
10th percentile, and (5) BMI or waist circumference 90th
percentile. For adolescents, BMI and waist circumference
mayrepresentdiﬀerentanthropometriccharacteristics,sowe
used either BMI or waist circumference for general or central
obesity surrogate markers to represent obesity status.
2.4. Statistical Analysis. We used mean and standard devi-
ation (SD) to describe the distribution of anthropometric
measures, blood pressure and biochemical levels. Frequency
(n) and percentage (%) were used to determine the preva-
lence of abnormal lifestyle and metabolic syndrome. For
comparison between the sexes, we used independent t-test
for continuous variables and used the chi-square (χ2)t e s t
to assess the association between categorical variables. We
used multivariate logistic regression analysis to evaluate the
odds ratio of anthropometric variables, such as BMI and
waist circumference, in relation to metabolic syndrome after
adjusting for age, cigarette smoking, alcohol consumption,
and pubertal status. A two-tailed P value less than 0.05
was considered statistically signiﬁcant. All statistical analyses
Cary, NC, USA).
3. Results
The distribution of anthropometric variables, blood pres-
sure, biochemical levels, and lifestyles in both genders are
shown in Table 1. In general, boys were taller, heavier, had
higher BMI, waist, and hip circumferences. Boys also had
higher SBP and glucose levels than girls (P<0.05). However,
girls had higher HDL-C levels than boys (P<0.05).
We further examined the clustering of these metabolic
components among the study population in Table 2.F o r
boys, the most prevalent clustering components were high
TG, low HDL-C, and abnormal anthropometric variables
(about 29.7%). In addition to these, the most frequent
clustering components for girls were low HDL-C, high BP,
and abnormal anthropometric variables (about 22.6%).
Table 3 shows the prevalence of metabolic syndrome and
its components in subjects with normalversus abnormal
BMI and normalversus abnormal waist circumference by
gender. The overall prevalence of MetS for boys was 4.8%;
and for girls was 3.9%. In boys, the prevalence of metabolic
syndrome for those with normal BMI (10th  BMI < 90th
percentile) was 2.1%, and 29.3% for relatively higher BMI
(90th percentile). The odds ratio (OR) of MetS was 13.7ISRN Cardiology 3
Table 1: The general characteristics of young adolescents in Taiwan.
Variables Boys (n = 764) Girls (n = 798)
Mean ± s.d. 10th 50th 90th Mean ± s.d. 10th 50th 90th
Age (years)∗ 13.0 ± 0.8 13.1 ± 0.8
Body height (cm)∗∗∗ 163.6 ± 8.1 152.5 164.0 173.5 157.7 ± 5.6 151.0 157.5 164.5
Body weight (kg)∗∗∗ 56.0 ± 13.0 41.0 54.0 73.0 49.8 ± 9.8 39.3 48.5 62.0
BMI (kg/m2)∗∗∗ 20.8 ± 3.9 16.6 20.0 26.1 20.0 ± 3.4 16.5 19.4 24.3
Waist circumference (cm)∗∗∗ 71.6 ± 10.2 61.0 69.0 86.0 67.5 ± 8.0 59.0 66.0 78.0
Hip circumference (cm) 89.1 ± 9.1 79.0 88.0 100.0 88.5 ± 7.6 80.0 88.0 98.0
Systolic BP (mmHg)∗∗∗ 118.0 ± 15.4 100.0 118.0 136.0 113.0 ± 13.5 97.0 113.0 129.0
Diastolic BP (mmHg) 68.3 ± 11.4 56.0 68.0 82.0 67.8 ± 10.8 55.0 68.0 80.0
Triglyceride (mg/dL)@ 67.9 ± 33.2 37.0 59.0 111.0 68.4 ± 29.1 41.0 62.0 102.0
HDL-cholesterol (mg/dL)∗∗∗ 50.0 ± 11.4 36.0 49.0 66.0 52.8 ± 12.1 39.0 51.0 69.0
Fasting glucose (mg/dL)∗∗ 89.1 ± 7.9 79.0 89.0 98.0 87.8 ± 8.0 78.0 87.0 98.0
Cigarette smoking1
No (%) 78.3$ 85
Yes (%) 5.0 4.5
Alcohol consumption2
No (%) 78.7 86
Yes (%) 0.5 0.7
Puberty development 3∗∗∗
Yes (%) 85.1 90.2
$The number of cigarette smoking, alcohol consumed, and puberty development not equal to 100% may be due to missing or incomplete data.
1Cigarette smoking: No: never smoking, Yes: current or previous smoking.
2Alcohol consumption: No: drinking less than once per week, Yes: drinking 1 per week.
3Puberty development: Yes: with any one of the three Tanner Stage 1 signs.
∗P < 0.05, ∗∗P<0.01, ∗∗∗P < 0.001 when boys compared with girls.
@TG was tested after log transformation.
(95% CI = 7.5–25.1) for subjects with higher BMIs when
compared to the normal BMI subjects. Also, the prevalence
of metabolic syndrome among those with normal and higher
waist circumference was 1.6% and 33.3%, respectively, and
the odds ratio was 20.9 (95% CI = 10.8–40.5).
In girls, the prevalence of metabolic syndrome for
normal BMI was 1.1%, and 28.4% for higher BMI. The
odds ratio of MetS was 26.0 (95% CI = 11.3–60.2) for
higher BMI when compared to the normal BMI subjects.
The prevalence of metabolic syndrome for normal and
higher waist circumference was 1.1% and 25.5%, respec-
tively, and the odds ratio was 23.0 (95% CI = 10.0–23.0).
Multivariate logistic regression models to assess the
association between BMI and/or waist circumference in
relation to metabolic syndrome are shown in Table 4.F o r
boys, after adjusting for age, cigarette smoking, alcohol
consumption, and pubertal status, every increasing unit of
BMI and every additionalcm of waist circumference was
signiﬁcantly associated with metabolic syndrome, with OR =
1.43 (95% CI = 1.30–1.55) and OR = 1.16 (95% CI = 1.12–
1.20), respectively. For girls, the odds ratio that increases of
1 unit BMI and 1cm waist circumference would increase
metabolicsyndromewas1.50(95% CI =1.35–1.67)and1.19
(95% CI = 1.14–1.24), respectively. After further adjusting
for BMI or waist circumference, waist circumference (central
obesity) for boys (OR = 1.14, 95% CI = 1.05–1.24) and
B M I( g e n e r a lo b e s i t y )f o rg i r l s( O R= 1.36, 95% CI = 1.13–
1.64) were the most signiﬁcant anthropometric variables
associated with metabolic syndrome.
4. Discussion
Metabolic syndrome is positively associated with the devel-
opment of cardiovascular diseases and Type 2 diabetes in
adults. Furthermore, the risk of metabolic syndrome can
be traced not only in adults but also in childhood and
adolescence. In our study, the prevalence of MetS was 4.8%
in boys and 3.9% in girls. The subjects with higher BMI
or waist circumference had 10 to 20 times higher odds
of MetS when compared to those with normal BMI or
waist circumference. Waist circumference and BMI were the
most signiﬁcant anthropometric variables associated with
metabolic syndrome for boys and girls, respectively.
T h ep r e v a l e n c eo fM e t Sv a r i e si nd i ﬀerent populations,
at about 20–40% in Western countries and 10–20% among
Asian adults [22]. For American adults, the prevalence of
Mets was 23.9% during the period from 1988 to 1994 [24].
Furthermore, the prevalence of MetS among US adolescents
was 4.2% to 6.4% from 1988 to 1992 and 1999 to 2000
[10]. However, the NHANES III ﬁndings suggested that the
prevalence of MetS was 9.2% in 1988–1994 [25].
In Taiwan, the prevalence of MetS is around 12.9% in
adults [23]. The components of metabolic syndrome were4 ISRN Cardiology
Table 2: Frequency and clustering of the metabolic syndrome (MetS) components among young adolescents in Taiwan.
Boys Girls
n (%) n (%) P-value
Frequency of MetS component@ (n = 764) (n = 798)
Abnormal anthropometric1 100 13.1 115 14.4 0.502
Abnormal BP2 131 17.2 138 17.3 0.988
Abnormal TG3 79 10.3 85 10.7 0.861
Abnormal HDL4 85 11.1 87 10.9 0.964
Abnormal Glu5 88 11.5 94 11.8 0.916
Clustering of MetS components# (n = 37) (n = 31)
A l l ﬁ v e c o m p o n e n t s 38 . 126 . 5 0 . 8 3 0
Four components 6 16.2 10 32.2 0.207
TG + HDL + BP + OB 4 10.8 5 16.1 0.777
Glu + other three6 2 5.4 5 16.1 0.295
Three components 28 75.7 19 61.3 0.309
TG + HDL + BP 2 6.5 2 5.4 0.747
TG + HDL + OB 11 29.7 1 3.2 0.011
TG + BP + OB 7 18.9 3 9.7 0.470
HDL + BP + OB 0 0 7 22.6 0.008
BP + Glu + OB 3 8.1 4 12.9 0.804
Glu + other two6 5 13.5 2 6.5 0.586
@The number and percentage of frequency among all study population which may be overlapping.
1Abnormal anthropometric is deﬁned as BMI or waist circumference 90th percentile.
2Abnormal BP is deﬁned as systolic or diastolic blood pressure 90th percentile.
3Abnormal TG is deﬁned as triglyceride 90th percentile.
4Abnormal HDL is deﬁned as HDL-cholesterol 10th percentile.
5Abnormal Glu is deﬁned as fasting glucose 90 percentile.
6Glu + other three is deﬁned as abnormal glucose plus any other three components of metabolic syndrome; Glu + other two is deﬁned as abnormal glucose
plus any other two components of the metabolic syndrome.
#The number and percentage of clustering is only among those subjects that have metabolic syndrome.
∗P values when boys compared with girls.
Table 3: Prevalence of the components of metabolic syndrome (MetS) among young adolescents with diﬀerent anthropometric status in
Taiwan.
Total BMI Waist Circumference
10–90th 90th 10–90th 90th
n (%) n (%) n (%) n (%) n (%)
Boys (n = 764) (n = 610) (n = 82) (n = 626) (n = 81)
Components of the MetS1
0 453 (59.3) 394 (64.6) 0 (0.0) 411 (65.6) 0 (0.0)
1 188 (24.6) 154 (25.3) 24 (29.3) 150 (24.0) 24 (29.6)
2 86 (11.3) 49 (8.0) 34 (41.4) 55 (8.8) 30 (37.1)
3 28 (3.6) 13 (2.1) 15 (18.3) 9 (1.4) 19 (3.4)
4 6 (0.8) 0 (0.0) 6 (7.3) 1 (0.2) 5 (6.2)
5 3 (0.4) 0 (0.0) 3 (3.7) 0 (0.0) 3 (3.7)
Girls (n = 798) (n = 643) (n = 81) (n = 631) (n = 94)
Components of the MetS1
0 454 (56.9) 393 (61.2) 0 (0.0) 395 (62.6) 0 (0.0)
1 214 (26.8) 186 (29.0) 19 (23.5) 173 (27.4) 30 (31.9)
2 99 (12.4) 56 (8.7) 39 (48.1) 56 (8.9) 40 (42.6)
3 19 (2.4) 4 (0.6) 15 (18.5) 4 (0.6) 15 (16.0)
4 10 (1.2) 3 (0.5) 7 (8.7) 3 (0.5) 7 (7.4)
5 2 (0.3) 1 (0.1) 1 (1.2) 0 (0.0) 2 (2.1)
1Components of metabolic syndrome include BMI or waist circumference 90th percentile, systolic or diastolic blood pressure 90th percentile, triglyceride
90th percentile, HDL-cholesterol 10th percentile, and fasting glucose 90 the percentile.ISRN Cardiology 5
Table 4: Multiple logistic regression analyses of anthropometric indices on the risk of metabolic syndrome.
Model A1 Model B2
OR 95% CI OR 95% CI
Boys (n = 764)
BMI 1.43 1.30–1.55 1.04 0.85–1.28
Waist circumference 1.16 1.12–1.20 1.14 1.05–1.24
Girls (n = 798)
BMI 1.50 1.35–1.67 1.36 1.13–1.64
Waist circumference 1.19 1.14–1.24 1.05 0.97–1.15
1Model A: adjusted for age, cigarette smoking, alcohol consumption, and stage of puberty.
2Model B: further adjusted for BMI or waist circumference.
Table 5: Age- and gender-speciﬁc percentile cut-oﬀ points among
study variables.
Variables Boys Girls
(N = 764) (N = 798)
12 YO n = 243 n = 229
BMI 24.8 23.6
Waist 84.0 75.0
Systolic BP 131.0 128.0
Diastolic BP 79.0 79.0
Triglyceride 117.0 106.0
HDL-Chol 38.0 39.0
Fasting glucose 100.0 99.0
13 YO n = 258 n = 297
BMI 25.8 24.7
Waist 85.0 78.0
Systolic BP 136.0 129.0
Diastolic BP 81.0 80.0
Triglyceride 109.0 102.0
HDL-Chol 37.0 40.0
Fasting glucose 97.0 97.0
14 YO n = 263 n = 272
BMI 26.9 24.6
Waist 89.0 78.0
Systolic BP 139.0 129.0
Diastolic BP 85.0 79.0
Triglyceride 110.0 97.0
HDL-Chol 35.0 38.0
Fasting glucose 97.0 97.0
also diﬀerent between the genders. Males had higher TG,
lower HDL-C, higher BP, and abnormal anthropometrics,
and females had lower HDL-C, higher BP and abnormal
anthropometrics [37]. The results of components of MetS
were similar to our ﬁndings; however, abnormal blood
pressureinboyswasnotsoprevalentinthisagegroup,which
may be due to the relative youth of this study population.
Therefore, the distribution and the clustering of MetS com-
ponentsarediﬀerentamongdiﬀerentageandgendergroups.
Obesity is positively associated with the development
of MetS, and this trend is consistent even among young
adolescents. When using BMI  95th percentile as obesity,
the prevalence of MetS among younger adolescents was
32.1%, compared to 7.1% among those with BMI between
85 and 95th percentiles [10]. Druet et al. have shown that by
using the modiﬁed NCEP-ATP III as criteria, the prevalence
of MetS among overweight students (25  BMI < 30) was
27.7% and among obese students (BMI  30) was 46.5%
[38]. These results were also similar to our ﬁnding that the
prevalence of MetS among those with higher BMI was 29.3%
and 28.4% for boys and girls, respectively (it was 2.1% in
boys and 1.1% in girls with normal BMI). This indicated
that the prevalence of MetS among overweight and obese
young adolescents were signiﬁcantly higher than normal
subjects. These high-risk populations should pay attention
to preventing MetS from developing in the future.
Body fat distribution may have diﬀerent clinical mean-
ings in adults and children. BMI is an indirect assessment
of total body fatness; however, waist circumference may
represent the amount of abdominal adiposity. Many studies
have shown that abdominal (central) adiposity, rather than
general obesity, is a stronger independent risk factor for
the occurrence MetS, CVD, and Type 2 diabetes for adults
[22, 25]. However, during childhood or adolescence, general
and central obesity may diﬀer due to dynamic growth
status. According to our study, after adjusting for BMI
or waist circumference, the association between anthropo-
metric indices and metabolic syndrome diﬀered for boys
and girls. For boys, waist circumference was the most
signiﬁcant variable associated with metabolic syndrome.
However, among girls, BMI had the greater impact in terms
ofmetabolicsyndrome.Inaddition,thePearson’scorrelation
coeﬃcients of BMI and waist circumference in relation to
body fat were 0.79 and 0.81, respectively, in boys; it was 0.95
and 0.81 in girls (data not shown). These ﬁndings suggest
that waist circumference for boys and BMI for girls had the
more signiﬁcant association with body fatness and so with
metabolic syndrome. Nevertheless, due to the limited nature
of our cross-sectional, further research would be required to
explain the possible mechanism.
Metabolic syndrome is associated with the development
of Type 2 diabetes and cardiovascular diseases, which
contribute to the morbidity and mortality from these
chronic diseases. Metabolic syndrome has become one of the
important issues for public health and clinical medicine for
preventing,notonlyinadultsbutchildrenfortheprevention6 ISRN Cardiology
of chronic diseases’ development. This study indicated that
abnormal BMI or waist circumference adolescents had 10 to
20 times higher odds of MetS when compared to normal
subjects. Obesity, either general or central adiposity, may
play an important role in the development of MetS among
children and young adolescents. Further study may be
indicated for obese, both general and central obese, young
adolescents to evaluate the association between obesity and
MetS for better understanding the possible mechanisms;
furthermore, the eﬀectiveness of weight control program on
thepreventionofobesityandMetSamongyoungadolescents
are needed in the future.
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